BCPC (Balchem) ROCE % : 14.05% (As of Mar. 2025)

View and export this data going back to 1986. Start your Free Trial

What is Balchem ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Balchem's annualized ROCE % for the quarter that ended in Mar. 2025 was 14.05%.

Balchem ROCE % Historical Data

The historical data trend for Balchem's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Balchem ROCE % Chart

Balchem Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

10.39

12.01

11.34

10.90

12.77

Balchem Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
ROCE %	Get a 7-Day Free Trial															11.60	12.43	13.01	13.03	14.05

Balchem ROCE % Calculation

Balchem's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	182.981	/	( ( (1597.211 - 148.491)	+	(1575.371 - 157.685) )	/ 2 )
	=	182.981	/	( (1448.72	+	1417.686)	/ 2 )
	=	182.981	/	1433.203
	=	12.77 %

Balchem's ROCE % of for the quarter that ended in Mar. 2025 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2025 )		(Q: Dec. 2024 )		(Q: Mar. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2025 )		(Q: Dec. 2024 )		(Q: Mar. 2025 )
	=	203.456	/	( ( (1575.371 - 157.685)	+	(1617.555 - 139.555) )	/ 2 )
	=	203.456	/	( ( 1417.686	+	1478 )	/ 2 )
	=	203.456	/	1447.843
	=	14.05 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2025) EBIT data.

Balchem (NAS:BCPC) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Balchem ROCE % Related Terms

Thank you for viewing the detailed overview of Balchem's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Balchem Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Balchem Corp (NAS:BCPC) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

BL9B:Germany BL9B:Germany

Address

5 Paragon Drive, Montvale, NJ, USA, 07645

Website

https://www.balchem.com

Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.

Executives

Van Gunsteren Job Leonard	officer: Vice President	52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
William A. Backus	officer: Chief Accounting Officer	52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
Michael Robert Sestrick	officer: Chief Technology Officer	52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
David B Fischer	director	425 WINTER ROAD, DELAWARE OH 43015
Michael Bent Tignor	officer: Chief Human Resources Officer	52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
Matthew David Wineinger	director	3605 GRAND VIEW COURT, ST CHARLES IL 60175
Theodore L Harris	director, officer: President and CEO	5200 BLAZER PARKWAY, DUBLIN OH 43017
Olivier Rigaud	director	CORBION NV, PIET HEINKADE 127, AMSTERDAM P7 1019 GM
Monica Vicente	director	C/O FRESH DEL MONTE PRODUCE INC., P.O. BOX 149222, CORAL GABLES FL 33114
Frederic Boned	officer: SVP/GM, Human Nutri. & Health	5 PARAGON DRIVE, MONTVALE NJ 07645
Hatsuki Miyata	officer: General Counsel and Secretary	5 PARAGON DRIVE, MONTVALE NJ 07645
Jonathan Harrison Griffin	officer: Vice President	52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
Martin Luther Reid	officer: Chief Supply Chain Officer	52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
Kathleen B Fish	director	ONE PROCTER & GAMBLE PLAZA, CINCINNATI OH 45202
James C Hyde	officer: Sr. Vice President	52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958